Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment.
Idiopathic pulmonary fibrosis (IPF) is a severe progressive and irreversible lung disease. Novel antifibrotic drugs that slow disease progression are now available. However, many issues regarding patient management remain unanswered, such as the choice between available drugs, their use in particular subgroups and clinical situations, time of treatment onset, termination, combination or switch, or nonpharmacologic management. To guide Swiss respiratory physicians in this evolving field still characterized by numerous areas of uncertainty, the Swiss Working Group for interstitial and rare lung diseases of the Swiss Respiratory Society provides a position paper on the diagnosis and treatment of IPF.
Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Manuela
M
Funke-Chambour
Andrea
A
Azzola
Dan
D
Adler
Constance
C
Barazzone-Argiroffo
Christian
C
Benden
Annette
A
Boehler
Pierre-Olivier
PO
Bridevaux
Martin
M
Brutsche
Christian F
CF
Clarenbach
Katrin
K
Hostettler
Rebekka
R
Kleiner-Finger
Laurent P
LP
Nicod
Paola M
PM
Soccal
Michael
M
Tamm
Thomas
T
Geiser
Romain
R
Lazor
D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D054990:Idiopathic Pulmonary Fibrosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D016040:Lung Transplantation